(+)-trans-(S)-allethrin increases activity ISO RGD:1350387 6480464 bioallethrin results in increased activity of GLO1 protein CTD PMID:32097678 1,2-dimethylhydrazine decreases expression ISO RGD:10653 6480464 1, 2-Dimethylhydrazine results in decreased expression of GLO1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of GLO1 mRNA CTD PMID:17108234 17alpha-ethynylestradiol increases expression ISO RGD:10653 6480464 Ethinyl Estradiol results in increased expression of GLO1 mRNA CTD PMID:17942748 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:10653 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10653 6480464 Tetrachlorodibenzodioxin affects the expression of GLO1 mRNA CTD PMID:18343893 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GLO1 mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10653 6480464 Tetrachlorodibenzodioxin results in decreased expression of GLO1 mRNA CTD PMID:16922920 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1350387 6480464 Tetrachlorodibenzodioxin affects the expression of GLO1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10653 6480464 Tetrachlorodibenzodioxin results in increased expression of GLO1 mRNA CTD PMID:15328365 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:10653 6480464 2 more ... CTD PMID:18343893 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:10653 6480464 2 more ... CTD PMID:16451863 3,4-dihydroxybenzaldehyde multiple interactions ISO RGD:1350387 6480464 protocatechualdehyde inhibits the reaction [sodium arsenite results in increased activity of GLO1 protein] CTD PMID:29732668 3,4-dihydroxybenzoic acid multiple interactions ISO RGD:10653 6480464 protocatechuic acid inhibits the reaction [Galactose results in decreased expression of and results in decreased activity of GLO1 protein] CTD PMID:22687555 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of GLO1 protein CTD PMID:26597043 3H-1,2-dithiole-3-thione decreases expression ISO RGD:10653 6480464 1, 2-dithiol-3-thione results in decreased expression of GLO1 mRNA CTD PMID:15302862 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GLO1 mRNA CTD PMID:36041667 4-hydroxycoumarin decreases activity ISO RGD:1350387 6480464 4-hydroxycoumarin analog results in decreased activity of GLO1 protein CTD PMID:33989593 acemetacin decreases activity ISO RGD:10653 6480464 acemetacin results in decreased activity of GLO1 protein CTD PMID:17243824 aflatoxin B1 increases expression ISO RGD:10653 6480464 Aflatoxin B1 results in increased expression of GLO1 mRNA CTD PMID:19770486 aldehydo-D-glucose multiple interactions ISO RGD:1350387 6480464 GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]] more ... CTD PMID:19833897 aldehydo-D-glucose multiple interactions EXP 6480464 morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 mRNA], morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 protein] CTD PMID:32643284 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of GLO1 mRNA CTD PMID:32643284 aldehydo-D-glucose decreases expression ISO RGD:1350387 6480464 Glucose results in decreased expression of GLO1 protein CTD PMID:19833897 all-trans-retinoic acid decreases expression ISO RGD:1350387 6480464 Tretinoin results in decreased expression of GLO1 mRNA CTD PMID:33167477 alpha-D-galactose multiple interactions ISO RGD:10653 6480464 Galactose results in decreased expression of and results in decreased activity of GLO1 protein, protocatechuic acid inhibits the reaction [Galactose results in decreased expression of and results in decreased activity of GLO1 protein] CTD PMID:22687555 AM-251 multiple interactions EXP 6480464 AM 251 inhibits the reaction [Dietary Carbohydrates results in decreased expression of GLO1 protein], AM 251 inhibits the reaction [Dietary Fats results in decreased expression of GLO1 protein] CTD PMID:26671069 AM-251 decreases expression EXP 6480464 AM 251 results in decreased expression of GLO1 protein CTD PMID:26671069 aminoguanidine multiple interactions ISO RGD:10653 6480464 pimagedine inhibits the reaction [Pyruvaldehyde results in decreased activity of GLO1 protein] CTD PMID:26723916 , PMID:29148590 aminoguanidine multiple interactions ISO RGD:1350387 6480464 pimagedine inhibits the reaction [Pyruvaldehyde results in decreased expression of GLO1 protein] CTD PMID:33930484 aminoguanidine multiple interactions EXP 6480464 pimagedine inhibits the reaction [Pyruvaldehyde results in decreased activity of GLO1 protein] CTD PMID:28919305 antirheumatic drug increases expression ISO RGD:1350387 6480464 Antirheumatic Agents results in increased expression of GLO1 mRNA CTD PMID:24449571 apocynin multiple interactions ISO RGD:10653 6480464 acetovanillone inhibits the reaction [Pyruvaldehyde results in decreased activity of GLO1 protein] CTD PMID:25042521 arsenite(3-) multiple interactions ISO RGD:1350387 6480464 arsenite promotes the reaction [G3BP1 protein binds to GLO1 mRNA], arsenite promotes the reaction [G3BP1 protein binds to GLO1 protein] CTD PMID:32406909 arsenous acid increases expression ISO RGD:1350387 6480464 Arsenic Trioxide results in increased expression of GLO1 mRNA CTD PMID:20458559 Benoxacor decreases expression ISO RGD:10653 6480464 benoxacor results in decreased expression of GLO1 mRNA CTD PMID:34850242 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of GLO1 mRNA CTD PMID:21839799 benzo[a]pyrene affects methylation ISO RGD:1350387 6480464 Benzo(a)pyrene affects the methylation of GLO1 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1350387 6480464 Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of GLO1 protein] CTD PMID:22138271 benzo[a]pyrene decreases expression ISO RGD:1350387 6480464 Benzo(a)pyrene results in decreased expression of GLO1 protein CTD PMID:22138271 benzo[b]fluoranthene decreases expression ISO RGD:10653 6480464 benzo(b)fluoranthene results in decreased expression of GLO1 mRNA CTD PMID:26377693 Bergenin multiple interactions ISO RGD:10653 6480464 bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in decreased expression of GLO1 protein], bergenin inhibits the reaction [Pyruvaldehyde results in decreased activity of GLO1 protein] CTD PMID:29148590 , PMID:31369791 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GLO1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GLO1 mRNA CTD PMID:36041667 bisphenol A decreases expression ISO RGD:10653 6480464 bisphenol A results in decreased expression of GLO1 mRNA CTD PMID:35598803 bisphenol A increases expression ISO RGD:1350387 6480464 bisphenol A results in increased expression of GLO1 protein CTD PMID:33376534 bisphenol A affects expression ISO RGD:1350387 6480464 bisphenol A affects the expression of GLO1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1350387 6480464 bisphenol A results in decreased expression of GLO1 mRNA CTD PMID:29275510 bisphenol A increases expression ISO RGD:10653 6480464 bisphenol A results in increased expression of GLO1 mRNA CTD PMID:25594700 Bisphenol B increases expression ISO RGD:1350387 6480464 bisphenol B results in increased expression of GLO1 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GLO1 mRNA CTD PMID:36041667 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of GLO1 promoter CTD PMID:22457795 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GLO1 mRNA CTD PMID:33453195 CGP 52608 multiple interactions ISO RGD:1350387 6480464 CGP 52608 promotes the reaction [RORA protein binds to GLO1 gene] CTD PMID:28238834 chlordecone multiple interactions ISO RGD:10653 6480464 Chlordecone promotes the reaction [Biomarkers metabolite binds to GLO1 gene] CTD PMID:31084621 chloropicrin affects expression ISO RGD:1350387 6480464 chloropicrin affects the expression of GLO1 mRNA CTD PMID:26352163 chlorpyrifos decreases expression ISO RGD:10653 6480464 Chlorpyrifos results in decreased expression of GLO1 mRNA CTD PMID:37019170 clobetasol increases expression ISO RGD:10653 6480464 Clobetasol results in increased expression of GLO1 mRNA CTD PMID:27462272 copper atom increases expression ISO RGD:10653 6480464 Copper results in increased expression of GLO1 mRNA CTD PMID:17205981 copper(0) increases expression ISO RGD:10653 6480464 Copper results in increased expression of GLO1 mRNA CTD PMID:17205981 copper(II) sulfate decreases expression ISO RGD:1350387 6480464 Copper Sulfate results in decreased expression of GLO1 mRNA CTD PMID:19549813 crocin-1 multiple interactions ISO RGD:10653 6480464 crocin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in decreased activity of GLO1 protein] CTD PMID:30580027 CU-O LINKAGE decreases expression ISO RGD:1350387 6480464 cupric oxide results in decreased expression of GLO1 protein CTD PMID:25470785 Cuprizon multiple interactions ISO RGD:1350387 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of GLO1 protein CTD PMID:34122009 curcumin decreases activity ISO RGD:1350387 6480464 Curcumin results in decreased activity of GLO1 protein CTD PMID:18946510 cyclosporin A decreases expression ISO RGD:10653 6480464 Cyclosporine results in decreased expression of GLO1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1350387 6480464 Cyclosporine results in decreased expression of GLO1 mRNA CTD PMID:25562108 D-glucose decreases expression ISO RGD:1350387 6480464 Glucose results in decreased expression of GLO1 protein CTD PMID:19833897 D-glucose multiple interactions EXP 6480464 morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 mRNA], morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 protein] CTD PMID:32643284 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of GLO1 mRNA CTD PMID:32643284 D-glucose multiple interactions ISO RGD:1350387 6480464 GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]] more ... CTD PMID:19833897 desferrioxamine B multiple interactions ISO RGD:1350387 6480464 ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of GLO1 protein] CTD PMID:19515424 desferrioxamine B increases expression ISO RGD:1350387 6480464 Deferoxamine results in increased expression of GLO1 protein CTD PMID:19515424 diarsenic trioxide increases expression ISO RGD:1350387 6480464 Arsenic Trioxide results in increased expression of GLO1 mRNA CTD PMID:20458559 dicrotophos decreases expression ISO RGD:1350387 6480464 dicrotophos results in decreased expression of GLO1 mRNA CTD PMID:28302478 dihydroxyacetone affects response to substance ISO RGD:1350387 6480464 GLO1 protein affects the susceptibility to Dihydroxyacetone CTD PMID:32506039 dioxygen decreases expression ISO RGD:10653 6480464 Oxygen deficiency results in decreased expression of GLO1 protein CTD PMID:25937538 diuron decreases expression ISO RGD:1350387 6480464 Diuron results in decreased expression of GLO1 mRNA CTD PMID:35967413 doxorubicin multiple interactions ISO RGD:1350387 6480464 [troglitazone results in decreased expression of GLO1 mRNA] which results in increased susceptibility to Doxorubicin, troglitazone inhibits the reaction [GLO1 mRNA results in decreased susceptibility to Doxorubicin] CTD PMID:16085563 doxorubicin decreases response to substance ISO RGD:1350387 6480464 GLO1 mRNA results in decreased susceptibility to Doxorubicin CTD PMID:16085563 doxorubicin multiple interactions ISO RGD:10653 6480464 [Indomethacin results in decreased activity of GLO1 protein] which results in increased susceptibility to Doxorubicin, GLO1 protein results in decreased susceptibility to [Indomethacin co-treated with Doxorubicin] CTD PMID:17243824 enzyme inhibitor multiple interactions ISO RGD:1350387 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GLO1 protein CTD PMID:23301498 ethanol affects splicing ISO RGD:10653 6480464 Ethanol affects the splicing of GLO1 mRNA CTD PMID:30319688 ferric ammonium citrate multiple interactions ISO RGD:1350387 6480464 ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of GLO1 protein] CTD PMID:19515424 fluoxetine increases response to substance ISO RGD:10653 6480464 GLO1 protein results in increased susceptibility to Fluoxetine CTD PMID:22113448 galactose multiple interactions ISO RGD:10653 6480464 Galactose results in decreased expression of and results in decreased activity of GLO1 protein, protocatechuic acid inhibits the reaction [Galactose results in decreased expression of and results in decreased activity of GLO1 protein] CTD PMID:22687555 galangin multiple interactions ISO RGD:1350387 6480464 galangin results in decreased expression of and results in decreased activity of GLO1 protein CTD PMID:29113808 gliclazide multiple interactions EXP 6480464 Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein] CTD PMID:21439372 glucose decreases expression ISO RGD:1350387 6480464 Glucose results in decreased expression of GLO1 protein CTD PMID:19833897 glucose multiple interactions EXP 6480464 morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 mRNA], morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 protein] CTD PMID:32643284 glucose decreases expression EXP 6480464 Glucose results in decreased expression of GLO1 mRNA CTD PMID:32643284 glucose multiple interactions ISO RGD:1350387 6480464 GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]] more ... CTD PMID:19833897 glycolaldehyde decreases activity EXP 6480464 glycolaldehyde results in decreased activity of GLO1 protein CTD PMID:21378371 haloperidol multiple interactions ISO RGD:1350387 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of GLO1 protein CTD PMID:34122009 Honokiol multiple interactions ISO RGD:10653 6480464 honokiol inhibits the reaction [Pyruvaldehyde results in decreased activity of GLO1 protein] CTD PMID:26723916 indometacin multiple interactions ISO RGD:10653 6480464 [Indomethacin results in decreased activity of GLO1 protein] which results in increased susceptibility to Doxorubicin more ... CTD PMID:17243824 inulin multiple interactions ISO RGD:10653 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GLO1 mRNA CTD PMID:36331819 ivermectin decreases expression ISO RGD:1350387 6480464 Ivermectin results in decreased expression of GLO1 protein CTD PMID:32959892 L-ascorbic acid affects expression ISO RGD:10653 6480464 Ascorbic Acid affects the expression of GLO1 protein CTD PMID:19224539 L-methionine multiple interactions ISO RGD:1350387 6480464 Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of GLO1 protein] CTD PMID:22138271 limonene multiple interactions ISO RGD:10653 6480464 limonene inhibits the reaction [Pyruvaldehyde results in decreased activity of GLO1 protein] CTD PMID:28986142 lipopolysaccharide multiple interactions ISO RGD:1350387 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of GLO1 mRNA CTD PMID:35877022 Magnolol multiple interactions EXP 6480464 magnolol inhibits the reaction [Pyruvaldehyde results in decreased activity of GLO1 protein] CTD PMID:28919305 mangiferin increases expression EXP 6480464 mangiferin results in increased expression of GLO1 mRNA CTD PMID:24036348 mangiferin multiple interactions EXP 6480464 mangiferin results in increased expression of and results in increased activity of GLO1 protein CTD PMID:24036348 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of GLO1 protein CTD PMID:19826936 methidathion decreases expression ISO RGD:10653 6480464 methidathion results in decreased expression of GLO1 mRNA CTD PMID:34813904 methylglyoxal affects response to substance ISO RGD:1350387 6480464 GLO1 protein affects the susceptibility to Pyruvaldehyde CTD PMID:20093988 methylglyoxal increases expression ISO RGD:1350387 6480464 Pyruvaldehyde results in increased expression of GLO1 mRNA CTD PMID:30447388 methylglyoxal multiple interactions EXP 6480464 magnolol inhibits the reaction [Pyruvaldehyde results in decreased activity of GLO1 protein], pimagedine inhibits the reaction [Pyruvaldehyde results in decreased activity of GLO1 protein] CTD PMID:28919305 methylglyoxal decreases activity EXP 6480464 Pyruvaldehyde results in decreased activity of GLO1 protein CTD PMID:28919305 methylglyoxal decreases activity ISO RGD:10653 6480464 Pyruvaldehyde results in decreased activity of GLO1 protein CTD PMID:25042521 more ... methylglyoxal multiple interactions ISO RGD:10653 6480464 [TNFSF11 protein co-treated with Pyruvaldehyde] affects the expression of GLO1 protein more ... CTD PMID:25042521 more ... methylglyoxal decreases expression ISO RGD:1350387 6480464 Pyruvaldehyde results in decreased expression of GLO1 protein CTD PMID:25933243 , PMID:33930484 methylglyoxal affects expression ISO RGD:1350387 6480464 Pyruvaldehyde affects the expression of GLO1 protein CTD PMID:22917016 methylglyoxal multiple interactions ISO RGD:1350387 6480464 GLO1 protein affects the reaction [Pyruvaldehyde binds to HSPB1 protein] more ... CTD PMID:20093988 more ... monascin increases expression ISO RGD:1350387 6480464 monascin results in increased expression of GLO1 protein CTD PMID:23954466 Morroniside multiple interactions EXP 6480464 morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 mRNA], morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 protein] CTD PMID:32643284 N-methyl-4-phenylpyridinium increases expression ISO RGD:10653 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GLO1 protein CTD PMID:26558463 N-nitrosodiethylamine increases expression ISO RGD:10653 6480464 Diethylnitrosamine results in increased expression of GLO1 mRNA CTD PMID:17942915 N-nitrosodiethylamine decreases expression ISO RGD:10653 6480464 Diethylnitrosamine results in decreased expression of GLO1 mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions ISO RGD:10653 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of GLO1 mRNA] CTD PMID:17942915 nicotinamide multiple interactions EXP 6480464 [Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein more ... CTD PMID:21439372 okadaic acid decreases expression ISO RGD:1350387 6480464 Okadaic Acid results in decreased expression of GLO1 protein CTD PMID:19397276 okadaic acid multiple interactions ISO RGD:1350387 6480464 [Okadaic Acid co-treated with gambierol] results in decreased expression of GLO1 protein CTD PMID:19397276 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of GLO1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GLO1 mRNA CTD PMID:25729387 p-menthan-3-ol increases expression ISO RGD:1350387 6480464 Menthol results in increased expression of GLO1 protein CTD PMID:26760959 paracetamol affects expression ISO RGD:10653 6480464 Acetaminophen affects the expression of GLO1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GLO1 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10653 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GLO1 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of GLO1 mRNA CTD PMID:36331819 pirinixic acid decreases expression ISO RGD:10653 6480464 pirinixic acid results in decreased expression of GLO1 mRNA CTD PMID:18445702 pirinixic acid increases expression ISO RGD:10653 6480464 pirinixic acid results in increased expression of GLO1 mRNA CTD PMID:18301758 pterostilbene multiple interactions ISO RGD:1350387 6480464 pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of GLO1 protein] CTD PMID:33930484 quercetin increases expression ISO RGD:1350387 6480464 Quercetin results in increased expression of GLO1 protein CTD PMID:17292933 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein] CTD PMID:21439372 resveratrol increases expression ISO RGD:1350387 6480464 resveratrol results in increased expression of GLO1 protein CTD PMID:22917016 resveratrol multiple interactions ISO RGD:1350387 6480464 NFE2L2 protein affects the reaction [resveratrol affects the reaction [Pyruvaldehyde affects the expression of GLO1 protein]], resveratrol affects the reaction [Pyruvaldehyde affects the expression of GLO1 protein] CTD PMID:22917016 resveratrol increases activity EXP 6480464 resveratrol results in increased activity of GLO1 protein CTD PMID:21439372 sarin increases expression EXP 6480464 Sarin results in increased expression of GLO1 protein CTD PMID:28973502 silicon dioxide decreases activity ISO RGD:1350387 6480464 Silicon Dioxide results in decreased activity of GLO1 protein CTD PMID:19679115 silicon dioxide decreases expression ISO RGD:1350387 6480464 Silicon Dioxide results in decreased expression of GLO1 mRNA CTD PMID:19679115 sodium arsenite increases expression ISO RGD:1350387 6480464 sodium arsenite results in increased expression of GLO1 protein CTD PMID:21925251 sodium arsenite multiple interactions ISO RGD:1350387 6480464 protocatechualdehyde inhibits the reaction [sodium arsenite results in increased activity of GLO1 protein] CTD PMID:29732668 sodium arsenite increases activity ISO RGD:1350387 6480464 sodium arsenite results in increased activity of GLO1 protein CTD PMID:29732668 sodium arsenite decreases expression ISO RGD:1350387 6480464 sodium arsenite results in decreased expression of GLO1 protein CTD PMID:21925251 sodium fluoride decreases expression ISO RGD:10653 6480464 Sodium Fluoride results in decreased expression of GLO1 protein CTD PMID:28918527 sodium fluoride increases expression ISO RGD:10653 6480464 Sodium Fluoride results in increased expression of GLO1 mRNA CTD PMID:27862939 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein more ... CTD PMID:21439372 sulforaphane increases expression ISO RGD:1350387 6480464 sulforaphane results in increased expression of GLO1 protein CTD PMID:25933243 sulforaphane multiple interactions ISO RGD:1350387 6480464 sulforaphane inhibits the reaction [Pyruvaldehyde results in decreased expression of GLO1 protein] CTD PMID:25933243 sulindac decreases activity ISO RGD:10653 6480464 Sulindac results in decreased activity of GLO1 protein CTD PMID:17243824 temozolomide increases expression ISO RGD:1350387 6480464 Temozolomide results in increased expression of GLO1 mRNA CTD PMID:31758290 tetrachloromethane decreases expression ISO RGD:10653 6480464 Carbon Tetrachloride results in decreased expression of GLO1 mRNA CTD PMID:27339419 , PMID:31919559 thapsigargin decreases expression ISO RGD:10653 6480464 Thapsigargin results in decreased expression of GLO1 protein CTD PMID:24648495 tolmetin decreases activity ISO RGD:10653 6480464 Tolmetin results in decreased activity of GLO1 protein CTD PMID:17243824 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GLO1 mRNA CTD PMID:25729387 trichloroethene decreases expression ISO RGD:10653 6480464 Trichloroethylene results in decreased expression of GLO1 mRNA CTD PMID:19448997 troglitazone multiple interactions ISO RGD:1350387 6480464 [troglitazone results in decreased expression of GLO1 mRNA] which results in increased susceptibility to Doxorubicin, troglitazone inhibits the reaction [GLO1 mRNA results in decreased susceptibility to Doxorubicin] CTD PMID:16085563 troglitazone decreases activity EXP 6480464 troglitazone results in decreased activity of GLO1 mRNA, troglitazone results in decreased activity of GLO1 protein CTD PMID:11719831 troglitazone decreases activity ISO RGD:1350387 6480464 troglitazone results in decreased activity of GLO1 mRNA, troglitazone results in decreased activity of GLO1 protein CTD PMID:11719831 , PMID:12572858 troglitazone decreases expression ISO RGD:1350387 6480464 troglitazone results in decreased expression of GLO1 mRNA CTD PMID:12572858 uranium atom affects expression ISO RGD:1350387 6480464 Uranium affects the expression of GLO1 mRNA CTD PMID:15672453 valproic acid affects expression ISO RGD:1350387 6480464 Valproic Acid affects the expression of GLO1 mRNA CTD PMID:25979313 zomepirac decreases activity ISO RGD:10653 6480464 zomepirac results in decreased activity of GLO1 protein CTD PMID:17243824